Keppra (levetiracetam) Tablets and Oral Solution

October 8, 2003

Audience: Pharmacists, Neurologists, and other healthcare professionals

FDA and UCB Pharma advised healthcare professionals of the risk of dispensing errors between KEPPRA (levetiracetam), an antiepileptic, and KALETRA (lopinavir/ritonavir), an antiretroviral. Patients with epilepsy who do not receive their antiepileptic drug due to a dispensing error would be inadequately treated and could experience serious consequences, including status epilepticus.

[September, 2003 Letter - UCB Pharma] PDF Format

View comments

Hide
(web5)